Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67

United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

14 insiders · 119 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sean Maduck

See Remarks

—

$25.04M (22) scheduled

−$25.04M

52,938

0.0490%

$4.38M

+38.0%

Atabak Mokari

Chief Financial Officer

—

$18.73M (22) scheduled

−$18.73M

16,304

0.0151%

$1.35M

+30.2%

David L Mahoney

Director

—

$13.94M (5) scheduled

−$13.94M

1,133,539

1.05%

$93.72M

−8.0%

William Guyer

Chief Development Officer

—

$11.60M (15) scheduled

−$11.60M

4,313

0.0040%

$356.58K

−25.6%

Roberto Wandenkolk Vieira

President, Oncology

—

$8.13M (13) scheduled

−$8.13M

3,946

0.0037%

$326.24K

−3.0%

Joseph K Belanoff

Chief Executive Officer

—

$7.40M (4) scheduled

−$7.40M

2,565,489

2.37%

$212.10M

−5.8%

James N Wilson

Director

—

$5.08M (15) scheduled

−$5.08M

2,529,086

2.34%

$209.09M

−23.1%

G Leonard Baker Jr

Director

$3.31M (2)

—

+$3.31M

2,241,893

2.07%

$185.35M

+12.0%

Kimberly Park

Director

—

$3.27M (1) scheduled

−$3.27M

0

0.0000%

$0.00

—

Joseph Douglas Lyon

See Remarks

—

$3.19M (8) scheduled

−$3.19M

5,683

0.0053%

$469.85K

−42.6%

Gary Charles Robb

Chief Business Officer

—

$1.16M (1)

−$1.16M

114,059

0.1055%

$9.43M

+86.2%

Hazel Hunt

Chief Scientific Officer

—

—

—

255,437

0.2363%

$21.12M

+115.4%

Daniel N Swisher JR

Director

—

—

—

0

0.0000%

$0.00

—

Gillian Cannon

Director

—

—

—

0

0.0000%

$0.00

—